Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ibandronic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS known ✓ | P14324 | 19/20 | 0.93 |
| ▸ | GGPS1 | O95749 | 8/20 | 0.93 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.93 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.93 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.93 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.57 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.57 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.57 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ibandronic Acid SCHEMBL28564280 | 1.00 | FDPS (0.93) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL3415425 | 1.00 | FDPS (0.93) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL365290 | 1.00 | FDPS (0.93) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL3624745 | 0.98 | FDPS (0.90) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL163394 | 0.98 | FDPS (0.90) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL3630021 | 0.98 | FDPS (0.90) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL3628878 | 0.98 | FDPS (0.90) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL3419518 | 0.98 | FDPS (0.97) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL1579193 | 0.98 | FDPS (0.97) | FDPSGGPS1AGTR1OPRM1PDE3A | |
| Ibandronic Acid SCHEMBL1030766 | 0.98 | FDPS (0.97) | FDPSGGPS1AGTR1OPRM1PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3513782-A1 | GEL FORMULATIONS FOR ORAL ADMINISTRATION OF DRUGS, IN PARTICULAR TO DYSPHAGIC PATIENTS | Universita' Degli Studi Di Camerino (IT) | 2019-07-24 | — | — | EP | claimed |
| CN-103554177-B | A kind of method preparing sodium Ibandronate monohydrate | 安徽省先锋制药有限公司 | 2016-06-29 | — | — | CN | claimed |
| US-9044401-B2 | Composition for preventing or treating osteoporosis, and manufacturing method therefor | NAVIPHARM CO., LTD. (KR) | 2015-06-02 | — | — | US | claimed |
| CN-104277070-A | Preparation method of sodium ibandronate monohydrate | HUBEI WATERSTONE BIO PHARMACEUTICAL TECHNOLOGY CO LTD | 2015-01-14 | — | — | CN | claimed |
| US-20130096091-A1 | COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS, AND MANUFACTURING METHOD THEREFOR | DREAM PHARMA CORPORATION (KR) | 2013-04-18 | — | — | US | claimed |
| WO-2021161987-A1 | BISPHOSPHONATE-CONTAINING CARBON PARTICLE COMPOSITE AND METHOD FOR PRODUCING SAME | 国立研究開発法人産業技術総合研究所 | 2021-08-19 | — | — | WO | disclosed |
| EP-3513782-A1 | GEL FORMULATIONS FOR ORAL ADMINISTRATION OF DRUGS, IN PARTICULAR TO DYSPHAGIC PATIENTS | Universita' Degli Studi Di Camerino (IT) | 2019-07-24 | — | — | EP | disclosed |
| CN-106511356-B | A kind of ibandronic acid composition of sodium and preparation method thereof | 南京恒生制药有限公司 | 2019-02-26 | — | — | CN | disclosed |
| CN-109293695-A | Bis- phosphonopropyl of N-(3- hydroxyl -3,3-)-N- methylpentane -1- amine oxide and the like and purposes | 天津红日药业股份有限公司 | 2019-02-01 | — | — | CN | disclosed |
| CN-104922060-B | A kind of Ibandronate composition | 河北仁合益康药业有限公司 | 2017-10-20 | — | — | CN | disclosed |
| CN-106511356-A | Sodium ibandronate composition and preparation method thereof | 南京恒生制药有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-103554177-B | A kind of method preparing sodium Ibandronate monohydrate | 安徽省先锋制药有限公司 | 2016-06-29 | — | — | CN | disclosed |
| WO-2013109198-A1 | PROCESSES FOR THE PREPARATION OF SODIUM IBANDRONATE MONOHYDRATE POLYMORPHS A, B AND MIXTURE OF POLYMORPHS A WITH B | KOÇAK FARMA İLAÇ VE KİMYA SANAYİ ANONİM ŞİRKETİ (TR) | 2013-07-25 | — | — | WO | disclosed |
| US-20130096091-A1 | COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS, AND MANUFACTURING METHOD THEREFOR | DREAM PHARMA CORPORATION (KR) | 2013-04-18 | — | — | US | disclosed |
| EP-2581086-A2 | COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS, AND MANUFACTURING METHOD THEREFOR | Navipharm Co, Ltd (KR) | 2013-04-17 | — | — | EP | disclosed |
| EP-2470549-A1 | PROCESS FOR MAKING 1-HYDROXYALKYLIDENE-1,1-BIPHOSPHONIC ACIDS | Synthon B.V. (NL) | 2012-07-04 | — | — | EP | disclosed |
| WO-2011023280-A1 | PROCESS FOR MAKING 1-HYDROXYALKYLIDENE-1,1-BIPHOSPHONIC ACIDS | SYNTHON B.V. (NL) | 2011-03-03 | — | — | WO | disclosed |
| WO-2011016738-A1 | A PROCESS FOR THE SYNTHESIS OF 1-HYDROXY-3-(N-METHYLPENTYLAMINO) PROPYLIDENE BISPHOSPHONIC ACID MONOSODIUM SALT, MONOHYDRATE | ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) | 2011-02-10 | — | — | WO | disclosed |
| WO-2008058722-A1 | REAGENT AND USE THEREOF FOR THE PRODUCTION OF BISPHOSPHONATES | SANDOZ A/S (DK) | 2008-05-22 | — | — | WO | disclosed |
| EP-1923394-A1 | Reagent and use thereof for the production of bisphosphonates | Sandoz A/S (DK) | 2008-05-21 | — | — | EP | disclosed |